Development of a positioning strategy for communicating the benefits of the Biotech sector

Client Issue

Our client required a comprehensive strategic plan for Biotech that demonstrated with robust evidence the health and economic value of the sector in Europe.

CRA Approach

CRA carried out an interview program to collect the perspectives of stakeholders and policy makers in Brussels on the challenges facing the biotech sector. The program documented the health and economic value of the sector for Europe using the latest evidence and articulated the relationship between the biotech value story and the policy environment.

Client Impact

The project provided the client with evidence that the healthcare biotech industry adds value in two quite distinct ways. First, it creates preventive and therapeutic solutions to combat serious diseases; and, second, it is a high technology innovative industry, which competes effectively in world markets, creating employment and wealth and supporting economic growth in Europe.

Related capabilities